Mersana Therapeutics

Mersana Therapeutics

Mersana Therapeutics

Rewriting the rules for immunoconjugate therapies.
Founded
2005
Raised
$108M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$75,000,000
IPO - 2017
$33,000,000
Venture capital (Series C) - 2016
Wellington Management NEA Rock Springs Capital +3
Team Size
1–10
Employees
Xconomy

FDA Puts Mersana Cancer Study on Partial Hold After Patient Death

Health
$75,000,000 IPO
PE HUB

VC-backed Mersana Therapeutics debuts IPO

Stock markets Health
$33,000,000 Venture capital (Series C)
biospace , mersana

Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million

Health Funding